FDA NDC Directory · JSON-LD · Markdown

Paclitaxel protein-bound particles for injectable suspension (albumin-bound)

NDC 68001-651 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION

Generic namePaclitaxel
Labeler / ManufacturerBluePoint Laboratories
Marketing categoryAbbreviated NDA (generic) · App ANDA216355
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION · INTRAVENOUS
Active ingredientsPACLITAXEL (100 mg/20mL)
Marketing started20250718
Package count1

External sources

Source: openFDA. Public-domain (CC0).